NASDAQ
DNAPrint Genomics, Inc. (DNAG) has a price/fcf ratio of -0.54x as of Tuesday, May 26, 2026. This represents a 93.56% increase compared to its 12-month average of -8.35x. The price-to-free-cash-flow ratio measures a stock's price relative to its free cash flow per share, reflecting how efficiently a company generates cash.
No price data available for this timeframe.